McQuaid, KR.; Laine, L. (maio de 2008). "A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic procedures.". Gastrointest Endosc67 (6): 910–23. PMID18440381. doi:10.1016/j.gie.2007.12.046.
Riezzo I, Centini F, Neri M, Rossi G, Spanoudaki E, Turillazzi E, Fineschi V (2009). "Brugada-like EKG pattern and myocardial effects in a chronic propofol abuser". Clin Toxicol (Phila)47 (4): 358–63. PMID19514884. doi:10.1080/15563650902887842.
Roussin A, Montastruc JL, Lapeyre-Mestre M (21 de outubro de 2007). "Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature". Fundamental and Clinical Pharmacology21 (5): 459–66. PMID17868199. doi:10.1111/j.1472-8206.2007.00497.x.
Charatan F (2009). "Concerns mount over recreational use of propofol among US healthcare professionals". BMJ339: b3673. PMID19737827. doi:10.1136/bmj.b3673.
Iwersen-Bergmann S, Rösner P, Kühnau HC, Junge M, Schmoldt A (2001). "Death after excessive propofol abuse". International Journal of Legal Medicine114 (4–5): 248–51. PMID11355404. doi:10.1007/s004149900129.
Kranioti EF, Mavroforou A, Mylonakis P, Michalodimitrakis M. (22 de marzo de 2007). "Lethal self administration of propofol (Diprivan): A case report and review of the literature". Forensic Science International167 (1): 56–8. PMID16431058. doi:10.1016/j.forsciint.2005.12.027.
Vesta, Kimi; Shaunta' Martina, Ellen Kozlowski (25 de abril de 2009). "Propofol-Induced Priapism, a Case Confirmed with Rechallenge". The Annals of Pharmacotherapy40 (5): 980–982. PMID16638914. doi:10.1345/aph.1G555.
Vasile B, Rasulo F, Candiani A, Latronico N (2003). "The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome". Intensive Care Medicine29 (9): 1417–25. PMID12904852. doi:10.1007/s00134-003-1905-x.
Trapani G, Altomare C, Liso G, Sanna E, Biggio G (febreiro de 2000). "Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery". Curr. Med. Chem.7 (2): 249–71. PMID10637364. doi:10.2174/0929867003375335.
Kotani Y, Shimazawa M, Yoshimura S, Iwama T, Hara H. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neuroscience and Therapeutics. 2008 Summer;14(2):95–106. doi10.1111/j.1527-3458.2008.00043.xPMID 18482023
Trapani G, Latrofa A, Franco M, Altomare C, Sanna E, Usala M, Biggio G, Liso G. Propofol analogues. Synthesis, relationships between structure and affinity at GABAA receptor in rat brain, and differential electrophysiological profile at recombinant human GABAA receptors. Journal of Medicinal Chemistry. 21 de maio de 1998;41(11):1846–54. doi10.1021/jm970681hPMID 9599235
Krasowski MD, Hong X, Hopfinger AJ, Harrison NL. 4D-QSAR analysis of a set of propofol analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor. Journal of Medicinal Chemistry. 18 de xullo de 2002;45(15):3210–21. doi10.1021/jm010461aPMID 12109905
Haeseler G, Karst M, Foadi N, Gudehus S, Roeder A, Hecker H, Dengler R, Leuwer M. High-affinity blockade of voltage-operated skeletal muscle and neuronal sodium channels by halogenated propofol analogues. British Journal of Pharmacology. 2008 Sep;155(2):265-75. doi10.1038/bjp.2008.255PMID 18574460
Fowler CJ (febreiro de 2004). "Possible involvement of the endocannabinoid system in the actions of three clinically used drugs". Trends Pharmacol. Sci.25 (2): 59–61. doi:10.1016/j.tips.2003.12.001.
Lee U, Mashour GA, Kim S, Noh GJ, Choi BM. (2009). Propofol induction reduces the capacity for neural information integration: implications for the mechanism of consciousness and general anesthesia. Conscious Cogn. 18(1):56–64.doi10.1016/j.concog.2008.10.005PMID 19054696
Stein M; et al. (setembro de 2012). "Azo-Propofols: Photochromic Potentiators of GABAA Receptors". Angewandte Chemie International Edition51 (42): 15000–4. PMID22968919. doi:10.1002/anie.201205475.
Yip G, Z.-W Chen, Edge C J, Smith E H, Dickinson R, Hohenester, E, Townsend R R, Fuchs K, Sieghart W, Evers A S, Franks N P (setembro de 2013). "A propofol binding site on mammalian GABAAreceptors identified by photolabeling". Nature Chemical Biology9 (11): 715–720. doi:10.1038/nchembio.1340.
Kvam C, Granese D, Flaibani A, Pollesello P, Paoletti S. (1993). "Hyaluronan can be protected from free-radical depolymerization by 2, 6-diisopropylphenol, a novel radical scavenger". Biochem. Biophys. Res. Comm.193 (3): 927–33. PMID8391811. doi:10.1006/bbrc.1993.1714.
Sebel, Peter ; Lowdon, Jane. Propofol: A New Intravenous Anesthetic.
Anesthesiology: agosto de 1989 - Volume 71 - Issue 2 - ppg 260-277. [1]Arquivado 07 de outubro de 2014 en Wayback Machine.
McQuaid, KR.; Laine, L. (maio de 2008). "A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic procedures.". Gastrointest Endosc67 (6): 910–23. PMID18440381. doi:10.1016/j.gie.2007.12.046.
Riezzo I, Centini F, Neri M, Rossi G, Spanoudaki E, Turillazzi E, Fineschi V (2009). "Brugada-like EKG pattern and myocardial effects in a chronic propofol abuser". Clin Toxicol (Phila)47 (4): 358–63. PMID19514884. doi:10.1080/15563650902887842.
Roussin A, Montastruc JL, Lapeyre-Mestre M (21 de outubro de 2007). "Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature". Fundamental and Clinical Pharmacology21 (5): 459–66. PMID17868199. doi:10.1111/j.1472-8206.2007.00497.x.
Charatan F (2009). "Concerns mount over recreational use of propofol among US healthcare professionals". BMJ339: b3673. PMID19737827. doi:10.1136/bmj.b3673.
Iwersen-Bergmann S, Rösner P, Kühnau HC, Junge M, Schmoldt A (2001). "Death after excessive propofol abuse". International Journal of Legal Medicine114 (4–5): 248–51. PMID11355404. doi:10.1007/s004149900129.
Kranioti EF, Mavroforou A, Mylonakis P, Michalodimitrakis M. (22 de marzo de 2007). "Lethal self administration of propofol (Diprivan): A case report and review of the literature". Forensic Science International167 (1): 56–8. PMID16431058. doi:10.1016/j.forsciint.2005.12.027.
Vesta, Kimi; Shaunta' Martina, Ellen Kozlowski (25 de abril de 2009). "Propofol-Induced Priapism, a Case Confirmed with Rechallenge". The Annals of Pharmacotherapy40 (5): 980–982. PMID16638914. doi:10.1345/aph.1G555.
Vasile B, Rasulo F, Candiani A, Latronico N (2003). "The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome". Intensive Care Medicine29 (9): 1417–25. PMID12904852. doi:10.1007/s00134-003-1905-x.
Trapani G, Altomare C, Liso G, Sanna E, Biggio G (febreiro de 2000). "Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery". Curr. Med. Chem.7 (2): 249–71. PMID10637364. doi:10.2174/0929867003375335.
Kotani Y, Shimazawa M, Yoshimura S, Iwama T, Hara H. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neuroscience and Therapeutics. 2008 Summer;14(2):95–106. doi10.1111/j.1527-3458.2008.00043.xPMID 18482023
Trapani G, Latrofa A, Franco M, Altomare C, Sanna E, Usala M, Biggio G, Liso G. Propofol analogues. Synthesis, relationships between structure and affinity at GABAA receptor in rat brain, and differential electrophysiological profile at recombinant human GABAA receptors. Journal of Medicinal Chemistry. 21 de maio de 1998;41(11):1846–54. doi10.1021/jm970681hPMID 9599235
Krasowski MD, Jenkins A, Flood P, Kung AY, Hopfinger AJ, Harrison NL (abril de 2001). "General anesthetic potencies of a series of propofol analogs correlate with potency for potentiation of gamma-aminobutyric acid (GABA) current at the GABA(A) receptor but not with lipid solubility". J. Pharmacol. Exp. Ther.297 (1): 338–51. PMID11259561.
Krasowski MD, Hong X, Hopfinger AJ, Harrison NL. 4D-QSAR analysis of a set of propofol analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor. Journal of Medicinal Chemistry. 18 de xullo de 2002;45(15):3210–21. doi10.1021/jm010461aPMID 12109905
Haeseler G, Karst M, Foadi N, Gudehus S, Roeder A, Hecker H, Dengler R, Leuwer M. High-affinity blockade of voltage-operated skeletal muscle and neuronal sodium channels by halogenated propofol analogues. British Journal of Pharmacology. 2008 Sep;155(2):265-75. doi10.1038/bjp.2008.255PMID 18574460
Lee U, Mashour GA, Kim S, Noh GJ, Choi BM. (2009). Propofol induction reduces the capacity for neural information integration: implications for the mechanism of consciousness and general anesthesia. Conscious Cogn. 18(1):56–64.doi10.1016/j.concog.2008.10.005PMID 19054696
Stein M; et al. (setembro de 2012). "Azo-Propofols: Photochromic Potentiators of GABAA Receptors". Angewandte Chemie International Edition51 (42): 15000–4. PMID22968919. doi:10.1002/anie.201205475.
Kvam C, Granese D, Flaibani A, Pollesello P, Paoletti S. (1993). "Hyaluronan can be protected from free-radical depolymerization by 2, 6-diisopropylphenol, a novel radical scavenger". Biochem. Biophys. Res. Comm.193 (3): 927–33. PMID8391811. doi:10.1006/bbrc.1993.1714.
Sebel, Peter ; Lowdon, Jane. Propofol: A New Intravenous Anesthetic.
Anesthesiology: agosto de 1989 - Volume 71 - Issue 2 - ppg 260-277. [1]Arquivado 07 de outubro de 2014 en Wayback Machine.